Medical technology working group
Considering the unique issues affecting clinical trials on medical devices
The main focus of the medical technology working group is clinical trials and studies on medical devices in accordance with the German Medical Devices Act (MPG). The goal of the joint activities is to ensure the conformity and quality of clinical trials on medical devices in accordance with the German Medical Devices Act.
Checklists and guidelines are to be developed which take account of the unique issues facing clinical trials on medical devices:
- No double blinding option
- Invasiveness of the intervention
- Consideration of benefit vs. harm
- Rapid enhancement of the state of the art
- Dependency on special user know-how, operational environment, etc.
Sub-issues are:
- Support for usability tests in the context of evaluation trials
- Health Technology Assessment (HTA) and InnoHTA
- Trials in the context of telemedicine
- Special trial requirements for the subject of "Plug&Play"
- Integration of method approaches from the fields of clinical trial, usability and effectiveness trials
- Trial requirements relating to complex product and treatment systems with medical devices
- Consideration/development of registers within the trial context
In April 2008, the medical technology working group was officially approved by the Board of Directors following its constituent meeting. The group is now planning a study of the topics in preparation for projects on the key activities mentioned.
(Letzte Aktualisierung: 04.07.2017)
Spokesperson
N.N.
Vice spokesperson
Thomas Norgall
Fraunhofer Institute for Integrated Circuits IIS
Phone: +49 9 131 776 73 05 | E-Mail
Contact at the TMF Office
Sebastian C. Semler
Phone: +4930 22 00 24 70 | E-Mail